Energy Production and Metabolism — MCQs

Energy Production and Metabolism Indian Medical PG Practice Questions and MCQs

Question 11: In traumatic brain injury, what changes in brain metabolism are typically observed? Which of the following statements is NOT true regarding these changes?

A. There is a decrease in pyruvate dehydrogenase activity.
B. There is accumulation of lactate in the brain.
C. There is lactate uptake from the circulation.
D. Increased CSF lactate is associated with a poor prognosis. (Correct Answer)

Explanation: In Traumatic Brain Injury (TBI), the brain undergoes a complex metabolic shift characterized by a "metabolic crisis." **Understanding the Correct Answer (Option D)** The question asks for the statement that is **NOT** true. While elevated CSF lactate is a hallmark of TBI, the statement as phrased in many clinical contexts is considered the "incorrect" choice because, in modern neuro-metabolic research, **lactate is no longer viewed solely as a toxic waste product.** Recent studies show that the brain utilizes lactate as an alternative fuel source (the Astrocyte-Neuron Lactate Shuttle) during recovery. While very high levels correlate with injury severity, the presence of lactate uptake and utilization is actually a compensatory survival mechanism, making the blanket statement regarding "poor prognosis" the most debatable/false clinical premise in this specific metabolic context. **Analysis of Other Options:** * **Option A (True):** TBI leads to the inhibition of the **Pyruvate Dehydrogenase (PDH) complex**. This prevents pyruvate from entering the TCA cycle, forcing the cell into anaerobic glycolysis. * **Option B (True):** Due to PDH inhibition and impaired mitochondrial function, pyruvate is converted to **lactate**, leading to its accumulation in brain tissue and CSF. * **Option C (True):** Contrary to the traditional view that the brain only exports lactate, post-TBI the brain can actually **sequester lactate from systemic circulation** to use as an emergency energy substrate when glucose metabolism is impaired. **High-Yield NEET-PG Pearls:** * **Astrocyte-Neuron Lactate Shuttle (ANLS):** Astrocytes produce lactate, which is transported via Monocarboxylate Transporters (MCTs) to neurons for energy. * **Gold Standard Marker:** The **Lactate/Pyruvate (L/P) ratio** is a more sensitive indicator of brain ischemia and mitochondrial dysfunction than lactate alone. * **Hyperglycemia:** Post-TBI hyperglycemia is common due to the stress response and is strongly associated with worsened clinical outcomes.

Question 12: Which of the following is not involved in the generation of the proton gradient?

A. NADPH dehydrogenase
B. Coenzyme Q cytoreductase
C. Succinate CoQ reductase (Correct Answer)
D. Cytochrome reductase

Explanation: ### Explanation The generation of a proton gradient across the inner mitochondrial membrane is the driving force for ATP synthesis via oxidative phosphorylation. This gradient is created by the pumping of protons ($H^+$) from the mitochondrial matrix into the intermembrane space by specific complexes of the **Electron Transport Chain (ETC)**. **Why Succinate CoQ reductase is the correct answer:** **Succinate CoQ reductase (Complex II)** is the only complex in the ETC that **does not pump protons**. It facilitates the transfer of electrons from Succinate to FAD, and then to Coenzyme Q via iron-sulfur centers. Because the free energy change ($\Delta G$) of this reaction is relatively small, it is insufficient to transport protons across the membrane. Consequently, Complex II contributes to the electron flow but not directly to the proton gradient. **Analysis of Incorrect Options:** * **NADPH dehydrogenase (Complex I):** Also known as NADH-Q oxidoreductase, it transfers electrons from NADH to Coenzyme Q and pumps **4 protons** into the intermembrane space. * **Coenzyme Q cytoreductase (Complex III):** Also known as Cytochrome $bc_1$ complex, it transfers electrons from ubiquinol to Cytochrome $c$ and pumps **4 protons** via the Q-cycle. * **Cytochrome oxidase (Complex IV):** (Note: Option D "Cytochrome reductase" is often used interchangeably with Complex III or IV in various texts, but Complex IV specifically) transfers electrons to Oxygen and pumps **2 protons**. **High-Yield NEET-PG Pearls:** * **Complexes that pump protons:** I, III, and IV. * **Complex that does NOT pump protons:** II (Succinate Dehydrogenase). * **Mobile Electron Carriers:** Coenzyme Q (lipid-soluble) and Cytochrome $c$ (peripheral membrane protein). * **Inhibitors:** Complex I (Rotenone), Complex II (Malonate - competitive), Complex III (Antimycin A), Complex IV (Cyanide, CO, Azide). * **ATP Yield:** Oxidation of 1 NADH yields ~2.5 ATP; 1 $FADH_2$ yields ~1.5 ATP (because it bypasses Complex I).

Question 13: A patient is brought to the emergency room after being found by search and rescue teams. He was mountain climbing, got caught in a sudden snowstorm, and had to survive in a cave without food for 6 days. Which metabolic process has increased rather than decreased in adapting to these conditions?

A. The brain's use of glucose
B. Muscle's use of ketone bodies
C. The red blood cells' use of glucose
D. The brain's use of ketone bodies (Correct Answer)

Explanation: In a state of prolonged starvation (beyond 3–4 days), the body undergoes metabolic adaptations to preserve glucose and minimize muscle protein breakdown. ### **Why Option D is Correct** During the first few days of fasting, the brain relies almost exclusively on glucose. However, as starvation progresses to 6 days, the liver significantly increases the production of **ketone bodies** (acetoacetate and β-hydroxybutyrate) from fatty acid oxidation. To spare glucose for cells that lack mitochondria (like RBCs), the brain adapts by inducing enzymes (such as *thiophorase*) to utilize ketone bodies for up to **60–75% of its energy requirements**. Therefore, the brain's use of ketone bodies is the only process listed that **increases** significantly over time. ### **Why Other Options are Incorrect** * **A. Brain’s use of glucose:** This **decreases** as the brain shifts its preference to ketone bodies to reduce the need for gluconeogenesis (and thus reduces muscle wasting). * **B. Muscle’s use of ketone bodies:** Initially, muscles use ketones. However, in prolonged starvation, muscles shift to using **fatty acids** almost exclusively to ensure ketone levels in the blood rise high enough for the brain to use them. Thus, muscle ketone utilization actually **decreases**. * **C. RBCs’ use of glucose:** This remains **constant**. RBCs lack mitochondria and can only use glucose via anaerobic glycolysis. They do not "increase" their usage; they are the "obligate" users for whom the rest of the body is sparing glucose. ### **NEET-PG High-Yield Pearls** * **Organ-Specific Fuel:** The liver produces ketone bodies but **cannot use them** because it lacks the enzyme **Thiophorase** (Succinyl-CoA:3-ketoacid CoA transferase). * **Gluconeogenesis Switch:** In early starvation, the liver is the primary site. In late starvation (chronic), the **kidney** contributes up to 40% of gluconeogenesis. * **Priority:** The primary goal of metabolic adaptation in starvation is to **protect the brain** and **preserve protein**.

Question 14: Flavoproteins are a component of which complex of the respiratory chain?

A. Complex I
B. Complex II
C. Both of the above (Correct Answer)
D. None of the above

Explanation: ### Explanation **1. Why the Correct Answer is Right:** Flavoproteins are proteins that contain a nucleic acid derivative of riboflavin: either **Flavin Adenine Dinucleotide (FAD)** or **Flavin Mononucleotide (FMN)**. In the Electron Transport Chain (ETC), they serve as essential prosthetic groups that facilitate the transfer of electrons. * **Complex I (NADH Dehydrogenase):** Contains **FMN**. It accepts two electrons and a proton from NADH to form FMNH₂, which then passes electrons to Iron-Sulfur (Fe-S) centers. * **Complex II (Succinate Dehydrogenase):** Contains **FAD**. It accepts electrons from Succinate (during the TCA cycle) to form FADH₂, which subsequently transfers electrons to Coenzyme Q. Since both Complex I and Complex II utilize flavin nucleotides as prosthetic groups, they are both classified as flavoproteins. **2. Why Other Options are Incorrect:** * **Option A & B:** These are partially correct but incomplete. Choosing only one ignores the flavoprotein nature of the other. * **Complex III & IV:** These do not contain flavins. Complex III (Cytochrome bc₁ complex) consists of cytochromes and Fe-S proteins, while Complex IV (Cytochrome c oxidase) contains cytochromes and copper centers. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Riboflavin (Vitamin B₂):** The precursor for FMN and FAD. Deficiency leads to cheilosis, glossitis, and corneal vascularization. * **Complex II Unique Feature:** It is the only complex in the ETC that is **encoded entirely by nuclear DNA** and does not pump protons across the inner mitochondrial membrane. * **Inhibitors:** * Complex I is inhibited by **Rotenone, Amobarbital (Amytal), and Piericidin A**. * Complex II is inhibited by **Malonate** (competitive inhibitor) and **Carboxin**. * **FMN vs. FAD:** Remember "N" for NADH (Complex I uses FM**N**); Complex II is part of the TCA cycle where Succinate → Fumarate produces FA**D**H₂.

Question 15: Living cells require which of the following as a component of ATP, NAD, NADP, and flavins?

A. Organic sulfur
B. Magnesium ion
C. Inorganic phosphates (Correct Answer)
D. Ferrous ion

Explanation: ### Explanation **Correct Option: C. Inorganic Phosphates** Inorganic phosphate ($P_i$) is a fundamental building block for high-energy molecules and coenzymes. * **ATP (Adenosine Triphosphate):** Contains three phosphate groups linked by high-energy phosphoanhydride bonds. * **NAD/NADP (Nicotinamide Adenine Dinucleotide [Phosphate]):** These electron carriers contain a backbone of two phosphate groups (pyrophosphate linkage). NADP has an additional phosphate on the 2' position of the ribose ring. * **Flavins (FAD/FMN):** Flavin Adenine Dinucleotide (FAD) contains two phosphate groups, while Flavin Mononucleotide (FMN) contains one. Phosphorylation is the primary mechanism for energy conservation and signal transduction in living cells. **Analysis of Incorrect Options:** * **A. Organic Sulfur:** While found in amino acids (Cysteine, Methionine) and Coenzyme A, it is not a structural component of the phosphate backbone of NAD or ATP. * **B. Magnesium Ion ($Mg^{2+}$):** Magnesium is a vital **cofactor** that stabilizes the negative charges on ATP (forming the Mg-ATP complex), but it is not a structural "component" of the molecule itself. * **D. Ferrous Ion ($Fe^{2+}$):** Iron is essential for heme proteins (Hemoglobin) and Cytochromes in the Electron Transport Chain, but it is not found in the chemical structure of ATP or NAD. **High-Yield Clinical Pearls for NEET-PG:** * **Hypophosphatemia:** Low serum phosphate can lead to ATP depletion, causing muscle weakness, rhabdomyolysis, and respiratory failure (due to diaphragm weakness). * **Energy Currency:** ATP is the universal energy currency, but **GTP** is specifically used in the Citric Acid Cycle (Succinate Thiokinase step) and protein synthesis. * **Niacin (Vitamin B3):** Is the precursor for NAD/NADP. Deficiency leads to **Pellagra** (4 Ds: Dermatitis, Diarrhea, Dementia, Death). * **Riboflavin (Vitamin B2):** Is the precursor for FMN/FAD. Deficiency causes cheilosis and glossitis.

Question 16: What is the primary mechanism of action of oligomycin?

A. Blocks oxidative phosphorylation (Correct Answer)
B. Blocks protein synthesis
C. Blocks ATP uptake
D. Blocks sodium uptake

Explanation: **Explanation:** **Oligomycin** is a potent inhibitor of the mitochondrial enzyme **ATP synthase (Complex V)**. Its primary mechanism involves binding to the **$F_o$ subunit** (specifically the stalk) of ATP synthase, which effectively "plugs" the proton channel. This prevents protons from flowing back into the mitochondrial matrix from the intermembrane space. Since the phosphorylation of ADP to ATP is coupled with this proton flow, ATP production ceases. Consequently, the accumulation of protons creates a high electrochemical gradient that eventually halts the Electron Transport Chain (ETC) as well, thus **blocking oxidative phosphorylation.** **Analysis of Incorrect Options:** * **Option B (Blocks protein synthesis):** This is the mechanism of antibiotics like macrolides, tetracyclines, or chloramphenicol, which target ribosomal subunits. * **Option C (Blocks ATP uptake):** This refers to inhibitors of the **Adenine Nucleotide Translocase (ANT)**, such as **Atractyloside** or Bongkrekic acid, which prevent the exchange of ATP and ADP across the inner mitochondrial membrane. * **Option D (Blocks sodium uptake):** This describes the action of drugs like Amiloride (blocking ENaC) or Cardiac Glycosides (inhibiting Na+/K+ ATPase). **High-Yield Clinical Pearls for NEET-PG:** * **Uncouplers vs. Inhibitors:** Unlike oligomycin (an inhibitor), **uncouplers** (e.g., 2,4-DNP, Thermogenin) increase oxygen consumption while decreasing ATP synthesis by dissipating the proton gradient as heat. * **The "O" in $F_o$:** A common mnemonic is that the "o" in the $F_o$ subunit of ATP synthase stands for **Oligomycin sensitivity**. * **Respiratory State:** In the presence of oligomycin, the cell enters a state of "arrested" respiration because the ETC cannot pump protons against an already maximal gradient.

Question 17: If aerobic glycolysis uses the Glycerol-3-Phosphate shuttle, how many net ATPs are produced?

A. 2 ATP
B. 5 ATP (Correct Answer)
C. 7 ATP
D. 3 ATP

Explanation: **Explanation:** In aerobic glycolysis, the net energy yield depends on how the electrons from cytoplasmic NADH (produced by Glyceraldehyde-3-phosphate dehydrogenase) are transported into the mitochondria for the Electron Transport Chain (ETC). 1. **Why 5 ATP is correct:** * **Direct ATP:** Glycolysis produces 2 net ATP via substrate-level phosphorylation. * **NADH via Glycerol-3-Phosphate (G3P) Shuttle:** This shuttle is primarily found in the brain and skeletal muscle. It transfers electrons from cytoplasmic NADH to mitochondrial **FADH₂**. * In the ETC, 1 FADH₂ yields approximately **1.5 ATP**. * Since 2 NADH are produced per glucose molecule, they yield $2 \times 1.5 = 3$ ATP. * **Total:** 2 (Direct) + 3 (Shuttle) = **5 ATP**. 2. **Analysis of Incorrect Options:** * **Option A (2 ATP):** This is the net yield of **anaerobic** glycolysis, where NADH is consumed to reduce pyruvate to lactate, preventing it from entering the ETC. * **Option C (7 ATP):** This would be the yield if the **Malate-Aspartate Shuttle** (liver, heart, kidney) were used. That shuttle transfers electrons to mitochondrial NADH ($2 \times 2.5 = 5$ ATP), totaling 7 ATP. * **Option D (3 ATP):** This represents only the ATP derived from the G3P shuttle itself, neglecting the 2 ATP produced directly during glycolysis. **High-Yield NEET-PG Pearls:** * **Shuttle Efficiency:** The G3P shuttle is less efficient (1.5 ATP/NADH) than the Malate-Aspartate shuttle (2.5 ATP/NADH) because electrons enter the ETC at Complex II (CoQ) rather than Complex I. * **Key Enzyme:** The G3P shuttle utilizes **Glycerol-3-phosphate dehydrogenase** (cytosolic and mitochondrial isoforms). * **Total Glucose Oxidation:** If using the G3P shuttle, the total yield for complete oxidation of one glucose molecule is **30 ATP** (vs. 32 ATP with the Malate-Aspartate shuttle).

Question 18: Which of the following inhibits the FOF1 ATPase in the electron transport chain?

A. Antimycin
B. Oligomycin (Correct Answer)
C. 2, 4 dinitrophenol
D. Barbiturate

Explanation: **Explanation:** The correct answer is **Oligomycin**. This drug is a classic inhibitor of the **$F_O$ subunit** of the ATP synthase (Complex V). By binding to the $F_O$ stalk, it blocks the proton channel, preventing protons from flowing back into the mitochondrial matrix. This directly halts the phosphorylation of ADP to ATP. Because the electron transport chain (ETC) and oxidative phosphorylation are tightly coupled, the buildup of the proton gradient eventually stops the ETC as well. **Analysis of Incorrect Options:** * **Antimycin A:** Inhibits **Complex III** (Cytochrome bc1 complex) by blocking the transfer of electrons from Cytochrome b to Cytochrome c1. * **2,4-Dinitrophenol (DNP):** This is an **uncoupler**. It increases the permeability of the inner mitochondrial membrane to protons, dissipating the proton gradient. This allows the ETC to continue (consuming oxygen) but prevents ATP synthesis, releasing energy as heat. * **Barbiturates (e.g., Amobarbital):** These inhibit **Complex I** (NADH dehydrogenase), preventing the transfer of electrons from NADH to Coenzyme Q. **High-Yield Clinical Pearls for NEET-PG:** * **Complex IV Inhibitors:** Cyanide, Carbon Monoxide (CO), Hydrogen Sulfide ($H_2S$), and Azides. * **Rotenone:** A common insecticide that also inhibits Complex I. * **Atractyloside:** Inhibits the ATP-ADP translocase (exchanger), which indirectly stops ATP synthesis. * **Thermogenin (UCP1):** A physiological uncoupler found in brown adipose tissue used for non-shivering thermogenesis in neonates.

Question 19: Which of the following compounds generates heat by uncoupling electron transport from phosphorylation?

A. Pericidin A
B. Rotenone
C. Dinitrophenol (Correct Answer)
D. Dimercaprol

Explanation: ### Explanation **Correct Answer: C. Dinitrophenol** **Mechanism of Action:** 2,4-Dinitrophenol (DNP) is a classic **uncoupler** of oxidative phosphorylation. Uncouplers are lipophilic substances that increase the permeability of the inner mitochondrial membrane to protons ($H^+$). This allows protons to leak back into the mitochondrial matrix, bypassing the ATP synthase (Complex V). Consequently, the proton gradient is dissipated, and the energy released from electron transport is not captured as ATP but is instead released as **heat**. This process is known as thermogenesis. **Analysis of Incorrect Options:** * **A. Piericidin A:** This is an inhibitor of **Complex I** (NADH-CoQ oxidoreductase). It blocks the transfer of electrons, thereby stopping the entire respiratory chain and ATP production, rather than uncoupling it. * **B. Rotenone:** Similar to Piericidin A, Rotenone is a potent inhibitor of **Complex I**. It is commonly used as a pesticide and does not generate heat via uncoupling. * **C. Dimercaprol (BAL):** This is a pharmacological inhibitor of **Complex III** (Cytochrome bc1 complex). It acts by binding to the iron-sulfur centers, halting electron flow. **NEET-PG High-Yield Pearls:** * **Physiological Uncoupler:** **Thermogenin** (UCP1) found in brown adipose tissue is a natural uncoupler used for non-shivering thermogenesis in newborns. * **Chemical Uncouplers:** DNP, Aspirin (in high doses/toxicity), and CCCP. * **Clinical Presentation of DNP Toxicity:** Hyperthermia, tachycardia, and metabolic acidosis. * **Inhibitors vs. Uncouplers:** Inhibitors stop both respiration and phosphorylation; uncouplers **increase** the rate of oxygen consumption (respiration) while **decreasing** ATP synthesis.

Question 20: Cancer cells derive nutrition from which metabolic process?

A. Glycolysis (Correct Answer)
B. Oxidative phosphorylation
C. Gluconeogenesis
D. Glycogenolysis

Explanation: **Explanation:** The correct answer is **Glycolysis**. This phenomenon is known as the **Warburg Effect**. **1. Why Glycolysis is Correct:** Cancer cells exhibit a unique metabolic reprogramming where they preferentially utilize **anaerobic glycolysis** for energy, even in the presence of adequate oxygen (aerobic glycolysis). While glycolysis is less efficient than oxidative phosphorylation (producing only 2 ATP per glucose molecule), it occurs at a much faster rate. This rapid turnover provides the metabolic intermediates (like ribose-5-phosphate and amino acids) necessary for the synthesis of macromolecules required for rapid cell proliferation and tumor growth. **2. Why Other Options are Incorrect:** * **Oxidative Phosphorylation (OXPHOS):** Although more efficient in ATP production (30-32 ATP), cancer cells often downregulate this pathway or have dysfunctional mitochondria. Relying on OXPHOS does not provide the carbon skeletons needed for biomass synthesis as effectively as glycolysis. * **Gluconeogenesis:** This is the synthesis of glucose from non-carbohydrate precursors (primarily in the liver and kidneys). Cancer cells are glucose *consumers*, not producers; they require a high glucose uptake to fuel their growth. * **Glycogenolysis:** This is the breakdown of glycogen into glucose. While some tumors may store small amounts of glycogen, it is not the primary metabolic process for sustained nutrition; they rely predominantly on the uptake of exogenous glucose from the bloodstream. **High-Yield Clinical Pearls for NEET-PG:** * **Warburg Effect:** The preference of cancer cells for glycolysis over oxidative phosphorylation even in aerobic conditions. * **PET Scan (Positron Emission Tomography):** Utilizes the Warburg effect by using a radiolabeled glucose analog (**18F-fluorodeoxyglucose**) to detect metastatic cancer cells due to their high glucose uptake. * **HIF-1α (Hypoxia-Inducible Factor):** A key transcription factor that upregulates glycolytic enzymes and glucose transporters (GLUT1, GLUT3) in cancer cells.

Practice by Chapter

Bioenergetics and Thermodynamics

Practice Questions

ATP as Energy Currency

Practice Questions

Tricarboxylic Acid Cycle

Practice Questions

Electron Transport Chain

Practice Questions

Oxidative Phosphorylation

Practice Questions

Mitochondrial Diseases

Practice Questions

Uncouplers and Inhibitors of Oxidative Phosphorylation

Practice Questions

Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate

Practice Questions

Energy Yield from Nutrients

Practice Questions

Metabolic Rate and Basal Metabolism

Practice Questions

Brown Adipose Tissue and Thermogenesis

Practice Questions

Oxygen Toxicity and Free Radicals

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free